In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Authors

• Ayesha S Ali
• Gregor Manukian
• Jennifer M Johnson
• Ioannis Vathiotis
• Rita Axelrod
• Scott W Keith
• Joseph Curry
• David Cognetti
• Adam Luginbuhl
• Athanassios Argiris
• Voichita Bar-Ad

Publication/Presentation Date

9-1-2023

Volume

117

Issue

1

First Page

181

Last Page

185

ISSN

1879-355X

Published In/Presented At

Ali, A. S., Manukian, G., Johnson, J. M., Vathiotis, I., Axelrod, R., Keith, S. W., Curry, J., Cognetti, D., Luginbuhl, A., Argiris, A., & Bar-Ad, V. (2023). In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. International journal of radiation oncology, biology, physics, 117(1), 181–185. https://doi.org/10.1016/j.ijrobp.2023.03.065

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

37019367

Department(s)

Administration and Leadership

Document Type

Article